@extends('layouts.app')
@section("content")
    <header>
        @include('layouts.header')
        <div class="row mt-4 py-4">

            <div class="col-lg-6 my-auto pe-lg-5 text-center px-lg-5 mx-auto pb-5">
                <h1 class="gradient-text fs-5 fw-bold text-uppercase">
                    Efficacy PROFILE
                </h1>
                <h1 class="default-color lh-base text-center px-lg-5">
                    Ruxolitinib Cream Case Reports
                </h1>
                <img src="{{asset('front-end/images/EfficacyProfile2.png')}}" class="img-fluid headar-img" alt="headerImg"
                     title="headerImg" loading="lazy" decoding="async">
            </div>

        </div>
    </header>

    <div class="container px-lg-5 py-5">
        <!-- cases -->
        <div class="dark-purple-bg p-lg-5 p-3 br-24 mb-4">
            <h5 class="fw-bold  text-white mb-4">
                Representative Clinical Images Showing F-VASI Responses
            </h5>
            <div class="bg-white px-4 fw-bold d-lg-flex justify-content-between ">
                <div class="d-inline-block me-4 py-1">
                    <span>
                        AGE :
                    </span>
                    <span class="dark-purple">
                        56
                    </span>
                </div>
                <div class="d-inline-block me-4 py-1">
                    <span>
                        SEX :
                    </span>
                    <span class="dark-purple">
                        Male
                    </span>
                </div>
                <div class="d-inline-block me-4 py-1">
                    <span>
                        DISEASE DURATION :
                    </span>
                    <span class="dark-purple">
                        21.6 Years
                    </span>
                </div>
                <div class="d-inline-block me-4 py-1">
                    <span>
                        TREATMENT :
                    </span>
                    <span class="dark-purple">
                        Ruxolitinib cream 1.5% BID
                    </span>
                </div>
            </div>
            <div class="row cases mt-4">
                <div class="col-lg-3 col-6 my-3">
                    <img src="{{asset('front-end/images/headerImg.png')}}" class="img-fluid" alt="">
                    <span class="text-center d-block text-white mt-2">
                        F-VASI 1.62
                    </span>
                </div>
                <div class="col-lg-3 col-6 my-3">
                    <img src="{{asset('front-end/images/headerImg.png')}}" class="img-fluid" alt="">
                    <span class="text-center d-block text-white mt-2">
                        F-VASI 1.62
                    </span>
                </div>
                <div class="col-lg-3 col-6 my-3">
                    <img src="{{asset('front-end/images/headerImg.png')}}" class="img-fluid" alt="">
                    <span class="text-center d-block text-white mt-2">
                        F-VASI 1.62
                    </span>
                </div>
                <div class="col-lg-3 col-6 my-3">
                    <img src="{{asset('front-end/images/headerImg.png')}}" class="img-fluid" alt="">
                    <span class="text-center d-block text-white mt-2">
                        F-VASI 1.62
                    </span>
                </div>
            </div>
        </div>
        <div class="dark-purple-bg p-lg-5 p-3 br-24 mb-4">
            <h5 class="fw-bold  text-white mb-4">
                Representative Clinical Images Showing F-VASI Responses
            </h5>
            <div class="bg-white px-4 fw-bold d-lg-flex justify-content-between ">
                <div class="d-inline-block me-4 py-1">
                    <span>
                        AGE :
                    </span>
                    <span class="dark-purple">
                        56
                    </span>
                </div>
                <div class="d-inline-block me-4 py-1">
                    <span>
                        SEX :
                    </span>
                    <span class="dark-purple">
                        Male
                    </span>
                </div>
                <div class="d-inline-block me-4 py-1">
                    <span>
                        DISEASE DURATION :
                    </span>
                    <span class="dark-purple">
                        21.6 Years
                    </span>
                </div>
                <div class="d-inline-block me-4 py-1">
                    <span>
                        TREATMENT :
                    </span>
                    <span class="dark-purple">
                        Ruxolitinib cream 1.5% BID
                    </span>
                </div>
            </div>
            <div class="row cases mt-4">
                <div class="col-lg-3 col-6 my-3">
                    <img src="{{asset('front-end/images/headerImg.png')}}" class="img-fluid" alt="">
                    <span class="text-center d-block text-white mt-2">
                        F-VASI 1.62
                    </span>
                </div>
                <div class="col-lg-3 col-6 my-3">
                    <img src="{{asset('front-end/images/headerImg.png')}}" class="img-fluid" alt="">
                    <span class="text-center d-block text-white mt-2">
                        F-VASI 1.62
                    </span>
                </div>
                <div class="col-lg-3 col-6 my-3">
                    <img src="{{asset('front-end/images/headerImg.png')}}" class="img-fluid" alt="">
                    <span class="text-center d-block text-white mt-2">
                        F-VASI 1.62
                    </span>
                </div>
                <div class="col-lg-3 col-6 my-3">
                    <img src="{{asset('front-end/images/headerImg.png')}}" class="img-fluid" alt="">
                    <span class="text-center d-block text-white mt-2">
                        F-VASI 1.62
                    </span>
                </div>
            </div>
        </div>
        <div class="dark-purple-bg p-lg-5 p-3 br-24 mb-4">
            <h5 class="fw-bold  text-white mb-4">
                Representative Clinical Images Showing F-VASI Responses
            </h5>
            <div class="bg-white px-4 fw-bold d-lg-flex justify-content-between ">
                <div class="d-inline-block me-4 py-1">
                    <span>
                        AGE :
                    </span>
                    <span class="dark-purple">
                        56
                    </span>
                </div>
                <div class="d-inline-block me-4 py-1">
                    <span>
                        SEX :
                    </span>
                    <span class="dark-purple">
                        Male
                    </span>
                </div>
                <div class="d-inline-block me-4 py-1">
                    <span>
                        DISEASE DURATION :
                    </span>
                    <span class="dark-purple">
                        21.6 Years
                    </span>
                </div>
                <div class="d-inline-block me-4 py-1">
                    <span>
                        TREATMENT :
                    </span>
                    <span class="dark-purple">
                        Ruxolitinib cream 1.5% BID
                    </span>
                </div>
            </div>
            <div class="row cases mt-4">
                <div class="col-lg-3 col-6 my-3">
                    <img src="{{asset('front-end/images/headerImg.png')}}" class="img-fluid" alt="">
                    <span class="text-center d-block text-white mt-2">
                        F-VASI 1.62
                    </span>
                </div>
                <div class="col-lg-3 col-6 my-3">
                    <img src="{{asset('front-end/images/headerImg.png')}}" class="img-fluid" alt="">
                    <span class="text-center d-block text-white mt-2">
                        F-VASI 1.62
                    </span>
                </div>
                <div class="col-lg-3 col-6 my-3">
                    <img src="{{asset('front-end/images/headerImg.png')}}" class="img-fluid" alt="">
                    <span class="text-center d-block text-white mt-2">
                        F-VASI 1.62
                    </span>
                </div>
                <div class="col-lg-3 col-6 my-3">
                    <img src="{{asset('front-end/images/headerImg.png')}}" class="img-fluid" alt="">
                    <span class="text-center d-block text-white mt-2">
                        F-VASI 1.62
                    </span>
                </div>
            </div>
        </div>

        <!--References  -->
        <div class="References mb-lg-5">
            <h6>
                References
            </h6>
            <ol class="px-0 mx-3">
                <li>
                    Howell MD, Kuo FI, Smith PA. Targeting the Janus kinase family in autoimmune skin
                    diseases.
                    Front Immunol. 2019; 10: 2342 [Internet]. 2019.
                </li>
                <li>Lumirix. Approved leaflet 29 August 2024.
                </li>
                <li>
                    Howell MD,
                    Kuo
                    FI, Smith PA. Targeting the Janus kinase family in autoimmune skin diseases. Front Immunol. 2019;
                    10:
                    2342 [Internet]. 2019.
                </li>
                <li>
                    Lumirix. Approved leaflet 29 August 2024.
                </li>
                <li> Smith P, Yao W, Shepard S,
                    Covington M,
                    Lee J, Lofland J, Naim A, Sheth T, Parikh B, Yeleswaram S. Developing a JAK inhibitor for targeted
                    local
                    delivery: ruxolitinib cream. Pharmaceutics. 2021 Jul 8;13(7):1044.
                </li>
                <li>
                    Birlea SA, Goldstein NB, Norris
                    DA.
                    Repigmentation through melanocyte regeneration in vitiligo. Dermatologic clinics. 2017 Apr
                    1;35(2):205-18.
                </li>
            </ol>
        </div>

    </div>

@endsection
